Status:

ACTIVE_NOT_RECRUITING

ATHN 9: Severe VWD Natural History Study

Lead Sponsor:

American Thrombosis and Hemostasis Network

Collaborating Sponsors:

Takeda

Conditions:

Von Willebrand Diseases

Eligibility:

All Genders

Brief Summary

ATHN 9 is a natural history study to assess the safety of various Von Willebrand Factor (VWF) regimens for different indications (on-demand, surgery and prophylaxis) in adult and pediatric participant...

Detailed Description

The overarching objective of this longitudinal, observational and prospective study is to characterize the safety and effectiveness of factor replacement in participants with clinically severe congeni...

Eligibility Criteria

Inclusion

  • Participants with severe Von Willebrand Disease with Type 3 VWD or VWF:RCo, VWF:GPlbM or VWF:Ag ≤30% of pooled normal control plasma on more than one occasion;
  • Participants with clinically severe VWD as defined by VWF:RCo, VWF:GPlbM or VWF:Ag ≤40% of normal with severe bleeding phenotype defined as requiring recurrent use of factor concentrates; and
  • Co-enrollment in the ATHNdataset.

Exclusion

  • Diagnosis of platelet-type VWD;
  • Diagnosis of acquired VWD (clinical diagnosis based on association with hypothyroidism, lymphoproliferative and myeloproliferative disorders, malignancies and cardiovascular disease, typically aortic stenosis or LVAD).

Key Trial Info

Start Date :

June 18 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 30 2026

Estimated Enrollment :

108 Patients enrolled

Trial Details

Trial ID

NCT03853486

Start Date

June 18 2019

End Date

July 30 2026

Last Update

March 12 2025

Active Locations (22)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (22 locations)

1

Center for Inherited Blood Disorders

Orange, California, United States, 92868

2

University of Colorado Denver Hemophilia and Thrombosis Center

Aurora, Colorado, United States, 80045

3

Connecticut Bleeding and Clotting Disorders Center

Farmington, Connecticut, United States, 06030

4

University of Florida Hemophilia Treatment Center

Gainesville, Florida, United States, 32610